186 related articles for article (PubMed ID: 34848566)
1. Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trial.
Yassi N; Zhao H; Churilov L; Campbell BCV; Wu T; Ma H; Cheung A; Kleinig T; Brown H; Choi P; Jeng JS; Ranta A; Wang HK; Cloud GC; Grimley R; Shah D; Spratt N; Cho DY; Mahawish K; Sanders L; Worthington J; Clissold B; Meretoja A; Yogendrakumar V; Ton MD; Dang DP; Phuong NTM; Nguyen HT; Hsu CY; Sharma G; Mitchell PJ; Yan B; Parsons MW; Levi C; Donnan GA; Davis SM
Stroke Vasc Neurol; 2022 Apr; 7(2):158-165. PubMed ID: 34848566
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.
Yassi N; Zhao H; Churilov L; Wu TY; Ma H; Nguyen HT; Cheung A; Meretoja A; Mai DT; Kleinig T; Jeng JS; Choi PMC; Duc PD; Brown H; Ranta A; Spratt N; Cloud GC; Wang HK; Grimley R; Mahawish K; Cho DY; Shah D; Nguyen TMP; Sharma G; Yogendrakumar V; Yan B; Harrison EL; Devlin M; Cordato D; Martinez-Majander N; Strbian D; Thijs V; Sanders LM; Anderson D; Parsons MW; Campbell BCV; Donnan GA; Davis SM;
Lancet Neurol; 2024 Jun; 23(6):577-587. PubMed ID: 38648814
[TBL] [Abstract][Full Text] [Related]
3. The spot sign and tranexamic acid on preventing ICH growth--AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial.
Meretoja A; Churilov L; Campbell BC; Aviv RI; Yassi N; Barras C; Mitchell P; Yan B; Nandurkar H; Bladin C; Wijeratne T; Spratt NJ; Jannes J; Sturm J; Rupasinghe J; Zavala J; Lee A; Kleinig T; Markus R; Delcourt C; Mahant N; Parsons MW; Levi C; Anderson CS; Donnan GA; Davis SM
Int J Stroke; 2014 Jun; 9(4):519-24. PubMed ID: 23981692
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
[TBL] [Abstract][Full Text] [Related]
5. Rationale and Design of a Randomized, Double-Blind Trial Evaluating the Efficacy of Tranexamic Acid on Hematoma Expansion and Peri-hematomal Edema in Patients with Spontaneous Intracerebral Hemorrhage within 4.5 h after Symptom Onset: The THE-ICH Trial Protocol.
Jiang C; Wang J; Wang J; Zhang J;
J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105136. PubMed ID: 32912508
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial.
Meretoja A; Yassi N; Wu TY; Churilov L; Sibolt G; Jeng JS; Kleinig T; Spratt NJ; Thijs V; Wijeratne T; Cho DY; Shah D; Cloud GC; Phan T; Bladin C; Moey A; Aviv RI; Barras CD; Sharma G; Hsu CY; Ma H; Campbell BCV; Mitchell P; Yan B; Parsons MW; Tiainen M; Curtze S; Strbian D; Tang SC; Harvey J; Levi C; Donnan GA; Davis SM
Lancet Neurol; 2020 Dec; 19(12):980-987. PubMed ID: 33128912
[TBL] [Abstract][Full Text] [Related]
7. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.
Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Christensen H; Ciccone A; Collins R; Czlonkowska A; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Krishnan K; Laska AC; Law ZK; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Seiffge D; Scutt P; Thanabalan J; Werring D; Whynes D; Bath PM;
Lancet; 2018 May; 391(10135):2107-2115. PubMed ID: 29778325
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial.
Liu J; Nie X; Gu H; Zhou Q; Sun H; Tan Y; Liu D; Zheng L; Zhao J; Wang Y; Cao Y; Zhu H; Zhang Y; Yi L; Pu Y; Wen M; Yang Z; Sun S; Wang W; Zhao X; Liu L; Wang Y
Stroke Vasc Neurol; 2021 Jun; 6(2):160-169. PubMed ID: 33795488
[TBL] [Abstract][Full Text] [Related]
9. Effect of Tranexamic Acid Administration on Remote Cerebral Ischemic Lesions in Acute Spontaneous Intracerebral Hemorrhage: A Substudy of a Randomized Clinical Trial.
Pszczolkowski S; Sprigg N; Woodhouse LJ; Gallagher R; Swienton D; Law ZK; Casado AM; Roberts I; Werring DJ; Al-Shahi Salman R; England TJ; Morgan PS; Bath PM; Dineen RA
JAMA Neurol; 2022 May; 79(5):468-477. PubMed ID: 35311937
[TBL] [Abstract][Full Text] [Related]
10. Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trial.
Sprigg N; Robson K; Bath P; Dineen R; Roberts I; Robinson T; Roffe C; Werring D; Al-Shahi Salman R; Pocock S; Duley L; England T; Whynes D; Ciccone A; Laska AC; Christensen H; Ozturk S; Collins R; Bereczki D; Egea-Guerrero JJ; Law ZK; Czlonkowska A; Seiffge D; Beredzie M;
Int J Stroke; 2016 Aug; 11(6):683-94. PubMed ID: 27048694
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial.
Polymeris AA; Karwacki GM; Siepen BM; Schaedelin S; Tsakiris DA; Stippich C; Guzman R; Nickel CH; Sprigg N; Kägi G; Vehoff J; Barinka F; Thilemann S; Maurer M; Wagner B; Traenka C; Gensicke H; De Marchis GM; Bonati LH; Fischer U; Z'Graggen WJ; Nedeltchev K; Wegener S; Baumgartner P; Engelter ST; Seiffge DJ; Peters N; Lyrer PA;
Stroke; 2023 Sep; 54(9):2223-2234. PubMed ID: 37466000
[TBL] [Abstract][Full Text] [Related]
12. Statistical analysis plan for the 'Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage' (TICH-2) trial.
Flaherty K; Bath PM; Dineen R; Law Z; Scutt P; Pocock S; Sprigg N;
Trials; 2017 Dec; 18(1):607. PubMed ID: 29262841
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic Acid for Prevention of Hematoma Expansion in Intracerebral Hemorrhage Patients With or Without Spot Sign.
Ovesen C; Jakobsen JC; Gluud C; Steiner T; Law Z; Flaherty K; Dineen RA; Christensen LM; Overgaard K; Rasmussen RS; Bath PM; Sprigg N; Christensen H
Stroke; 2021 Aug; 52(8):2629-2636. PubMed ID: 34000834
[TBL] [Abstract][Full Text] [Related]
14. Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial.
Brenner A; Afolabi A; Ahmad SM; Arribas M; Chaudhri R; Coats T; Cuzick J; Gilmore I; Hawkey C; Jairath V; Javaid K; Kayani A; Mutti M; Nadeem MA; Shakur-Still H; Stanworth S; Veitch A; Roberts I;
Trials; 2019 Jul; 20(1):467. PubMed ID: 31362765
[TBL] [Abstract][Full Text] [Related]
15. Tranexamic acid for acute intracerebral hemorrhage growth predicted by spot sign trial: Rationale and design.
Liu L; Wang Y; Meng X; Li N; Tan Y; Nie X; Liu D; Zhao X;
Int J Stroke; 2017 Apr; 12(3):326-331. PubMed ID: 28381202
[TBL] [Abstract][Full Text] [Related]
16. Prevention of haematoma progression by tranexamic acid in intracerebral haemorrhage patients with and without spot sign on admission scan: a statistical analysis plan of a pre-specified sub-study of the TICH-2 trial.
Ovesen C; Jakobsen JC; Gluud C; Steiner T; Law Z; Flaherty K; Dineen RA; Bath PM; Sprigg N; Christensen H
BMC Res Notes; 2018 Jun; 11(1):379. PubMed ID: 29895329
[TBL] [Abstract][Full Text] [Related]
17. Does tranexamic acid lead to changes in MRI measures of brain tissue health in patients with spontaneous intracerebral haemorrhage? Protocol for a MRI substudy nested within the double-blind randomised controlled TICH-2 trial.
Dineen RA; Pszczolkowski S; Flaherty K; Law ZK; Morgan PS; Roberts I; Werring DJ; Al-Shahi Salman R; England T; Bath PM; Sprigg N
BMJ Open; 2018 Feb; 8(2):e019930. PubMed ID: 29431141
[TBL] [Abstract][Full Text] [Related]
18. A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS]).
Mahmood A; Roberts I; Shakur H
Trials; 2017 Jul; 18(1):330. PubMed ID: 28716153
[TBL] [Abstract][Full Text] [Related]
19. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial.
Shakur H; Elbourne D; Gülmezoglu M; Alfirevic Z; Ronsmans C; Allen E; Roberts I
Trials; 2010 Apr; 11():40. PubMed ID: 20398351
[TBL] [Abstract][Full Text] [Related]
20. Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial (ISRCTN50867461).
Sprigg N; Renton CJ; Dineen RA; Kwong Y; Bath PM
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1312-8. PubMed ID: 24680087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
